Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pacshil 30 mg Injection
Manufacturer/Marketed By : Shilpa Medicare Ltd
$12.85 $10.03
Sidmex Inovia offers bulk export supply of Pacshil 30 mg Injection (Paclitaxel 30 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain...
Paclitaxel 30 mg
Active Pharmaceutical Ingredient
Pacshil 30 mg Injection
$12.85
$10.03
Sidmex Inovia offers bulk export supply of Pacshil 30 mg Injection (Paclitaxel 30 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Pacshil 260 mg Injection
Pacshil 30 mg Injection is an essential treatment option used in conjunction with other chemotherapy agents to combat various cancers, including breast cancer, ovarian cancer, and non-small cell lung cancer (NSCLC). This powerful medication, containing paclitaxel, operates by hindering the proliferation of cancer cells, effectively preventing them from dividing and growing. Administered via injection, Pacshil not only targets malignant cells but also plays a crucial role in enhancing the overall effectiveness of a comprehensive cancer treatment regimen. Patients should be aware of potential side effects, such as nausea, hair loss, and allergic reactions, which may occur during the course of therapy. Regular monitoring by healthcare professionals is vital to ensure safety and manage any adverse reactions. This medication should be used with caution in individuals with liver problems or those who are pregnant or breastfeeding, as it may pose risks. By understanding its function and adhering to medical guidance, patients can make informed decisions about their cancer treatment options with Pacshil.
Active Pharmaceutical Ingredient
Uses
• Pacshil 30 mg injection is primarily used in the treatment of non-small cell lung cancer (NSCLC). This type of cancer is the most common form of lung cancer and can be challenging to manage. By administering Pacshil 30 mg injection, healthcare providers aim to slow the progression of the disease and improve patient outcomes. It is typically considered when other treatment options may not be suitable.
• Another important application of Pacshil 30 mg injection is in the management of pancreatic cancer. This aggressive form of cancer often requires a multifaceted treatment approach. Pacshil 30 mg injection helps target cancer cells, potentially enhancing the effectiveness of other therapies. Patients receiving this treatment may experience improved control over their condition.
• Pacshil 30 mg injection is also utilized in the treatment of breast cancer, particularly in cases that are resistant to standard therapies. The formulation works by inhibiting specific pathways involved in tumor growth. By incorporating Pacshil 30 mg injection into the treatment plan, oncologists can offer patients a viable option to combat their cancer. This can be especially beneficial for those with advanced stages of the disease.
• In addition to its primary uses, Pacshil 30 mg injection may be considered in clinical settings for other types of cancers as part of a comprehensive treatment strategy. Oncologists evaluate each patient's unique situation before recommending Pacshil 30 mg injection. Its ability to target and inhibit tumor growth makes it a valuable option in cancer care. This flexibility in application allows for tailored treatment plans that can adapt to patient needs.
Benefits
Non-small cell lung cancer: Non-small cell lung cancer is one of the most common types of lung cancer and affects both people who smoke and those who never smoke. Pacshil Injection helps to treat non-small cell lung cancer and may be given alone or combined with other medicines. It is a strong and very toxic medicine. You should discuss the risks and benefits with your doctor. You should drink plenty of water to stay hydrated and avoid alcohol while you are receiving this treatment.
Pancreatic cancer: The pancreas is very important for the digestion of what you eat and also for the metabolism of blood sugar levels, as it produces the body's natural insulin. This medicine will help to control pancreatic cancer and will relieve symptoms such as loss of appetite or unexplained weight loss. Pacshil 30 mg helps stop the action of chemicals that help pancreatic cancer grow and spread. It will help you live longer and healthier.
Breast cancer: Paclitaxel Injection 30 mg is used to treat breast cancer. It may be used alone or with other medicines, including chemotherapy. It reduces the symptoms of breast cancer, such as lumpiness in the breast, nipple discharge that is bloody, or changes in the shape or texture of the breast. Pacshil Injection works by killing or stopping the growth of cancer cells and by stopping cancer cells from reproducing in the body. Discuss any side effects with your doctor if they bother you.
Side Effects
Like all medicines, Anti-cancer Drug Pacshil may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Hair Loss
• Infections
• Sores in Lips and Mouth
• Anaemia
• Tingling and Burning Sensation in the Hands and Feet
• Bleeding
• Irritation at the site of injection
• Nausea



